Cerevel Therapeutics
CERE
#2316
Rank
โ‚น739.81 B
Marketcap
โ‚น4,061
Share price
0.00%
Change (1 day)
114.73%
Change (1 year)

Revenue for Cerevel Therapeutics (CERE)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cerevel Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Archer Daniels Midland (ADM)
ADM
โ‚น7.515 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Campbell's
CPB
โ‚น917.41 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚น3.695 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Dupont De Nemours
DD
โ‚น1.127 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA